Compare Novartis with EMMSONS INT. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs EMMSONS INT. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS EMMSONS INT. NOVARTIS/
EMMSONS INT.
 
P/E (TTM) x 86.5 -0.0 - View Chart
P/BV x 2.8 - - View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 NOVARTIS   EMMSONS INT.
EQUITY SHARE DATA
    NOVARTIS
Mar-21
EMMSONS INT.
Mar-18
NOVARTIS/
EMMSONS INT.
5-Yr Chart
Click to enlarge
High Rs7708 9,722.2%   
Low Rs5013 16,319.2%   
Sales per share (Unadj.) Rs154.50-  
Earnings per share (Unadj.) Rs8.5-355.8 -2.4%  
Cash flow per share (Unadj.) Rs13.4-355.1 -3.8%  
Dividends per share (Unadj.) Rs10.000-  
Avg Dividend yield %1.60-  
Book value per share (Unadj.) Rs289.2-1,293.2 -22.4%  
Shares outstanding (eoy) m24.6912.00 205.8%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x4.1NM-  
Avg P/E ratio x75.10 -486,320.9%  
P/CF ratio (eoy) x47.50 -306,811.1%  
Price / Book Value ratio x2.20 -51,726.7%  
Dividend payout %118.10-   
Avg Mkt Cap Rs m15,69166 23,804.0%   
No. of employees `000NANA-   
Total wages/salary Rs m1,08537 2,951.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3,8140-  
Other income Rs m3326 5,992.8%   
Total revenues Rs m4,1466 74,828.5%   
Gross profit Rs m267-2,008 -13.3%  
Depreciation Rs m1229 1,383.4%   
Interest Rs m772,262 3.4%   
Profit before tax Rs m400-4,273 -9.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m191-3 -5,835.4%   
Profit after tax Rs m209-4,270 -4.9%  
Gross profit margin %7.0NM- 
Effective tax rate %47.80.1 62,220.0%   
Net profit margin %5.5NM- 
BALANCE SHEET DATA
Current assets Rs m9,224220 4,190.4%   
Current liabilities Rs m3,57320,641 17.3%   
Net working cap to sales %148.2NM- 
Current ratio x2.60 24,211.0%  
Inventory Days Days176NM- 
Debtors Days Days37NM- 
Net fixed assets Rs m2,4805,602 44.3%   
Share capital Rs m123120 102.9%   
"Free" reserves Rs m7,018-15,638 -44.9%   
Net worth Rs m7,141-15,518 -46.0%   
Long term debt Rs m0551 0.0%   
Total assets Rs m11,7035,829 200.8%  
Interest coverage x6.2-0.9 -699.1%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.30-   
Return on assets %2.4-34.4 -7.1%  
Return on equity %2.927.5 10.6%  
Return on capital %6.713.4 49.7%  
Exports to sales %9.3NM-  
Imports to sales %0NM-  
Exports (fob) Rs m354NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3540-   
Fx outflow Rs m9740-   
Net fx Rs m-6210-   
CASH FLOW
From Operations Rs m-69222 -3,105.0%  
From Investments Rs m952-69 -1,374.0%  
From Financial Activity Rs m-36859 -623.2%  
Net Cashflow Rs m-10912 -898.2%  

Share Holding

Indian Promoters % 0.0 52.9 -  
Foreign collaborators % 73.4 0.2 43,176.5%  
Indian inst/Mut Fund % 1.3 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 26.6 47.0 56.7%  
Shareholders   44,652 1,725 2,588.5%  
Pledged promoter(s) holding % 0.0 52.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   MADHUR INDUS.  JYOTIRGAMYA ENTERPRISES  CHANDRA PRAB  PARKER AGRO.  JAIPAN INDUSTRIES  



Today's Market

HUL's Quarterly Performance, Tata Motors on EV Battery Prices, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a flat note yesterday. Dalal street's greatest winning streak in over ten months came to an end when benchmark indices fell for the first time in eight sessions.

Related Views on News

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC?(Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost(Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs...(Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

5 Exciting 'Unlisted' Companies and How to Play Them(Views On News)

Oct 7, 2021

Here's how you can invest in some of the most exciting start-ups of the decade.

Modi's Big Move Could Boost these 5 Defence Stocks(Views On News)

Oct 11, 2021

To corporatise the defence sector, the Ministry of Defence (MoD) has dissolved the 250-year-old Ordnance Factory Board (OFB).

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Oct 19, 2021 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS - HEXA TRADEX COMPARISON

COMPARE NOVARTIS WITH

MARKET STATS